Outcomes of high-risk prostate-specific antigen level during active surveillance with targeted and systematic prostate biopsy.

Prostate cancer, especially in advanced stages such as castration-resistant prostate cancer, is challenging to treat. Traditional therapies targeting androgen receptor (AR) signaling have limited ...